Patents by Inventor Rod Hartwig

Rod Hartwig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for delivering active agents in transdermal drug delivery systems
    Patent number: 8865207
    Abstract: A blend of at least two polymers in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin.
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: October 21, 2014
    Assignee: Noven Pharmaceuticals, Inc.
    Inventors: David Kanios, Rod Hartwig
  • COMPOSITIONS AND METHODS FOR CONTROLLING DRUG LOSS AND DELIVERY IN TRANSDERMAL DRUG DELIVERY SYSTEMS
    Publication number: 20140243764
    Abstract: A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or release liner. The transdermal delivery device is manufactured to optimize drug loading while providing desirable adhesion to skin or mucosa as well as providing modulation of the drug delivery and profile.
    Type: Application
    Filed: February 27, 2014
    Publication date: August 28, 2014
    Applicant: Noven Pharmaceuticals, Inc.
    Inventors: David Kanios, Rod Hartwig, Juan Mantelle, David W. Houze
  • Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
    Patent number: 8703175
    Abstract: A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or release liner. The transdermal delivery device is manufactured to optimize drug loading while providing desirable adhesion to skin or mucosa as well as providing modulation of the drug delivery and profile.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: April 22, 2014
    Assignee: Noven Pharmaceuticals, Inc.
    Inventors: David P. Kanios, Rod Hartwig, Juan A. Mantelle, David W. Houze
  • COMPOSITIONS AND METHODS FOR DELIVERING ESTRADIOL IN TRANSDERMAL DRUG DELIVERY SYSTEMS
    Publication number: 20130317461
    Abstract: A blend of at least two polymers in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin.
    Type: Application
    Filed: December 14, 2012
    Publication date: November 28, 2013
    Applicant: Noven Pharmaceuticals, Inc.
    Inventors: David Kanios, Rod Hartwig
  • Inhibiting crystallization of steroidal hormones in transdermal delivery systems
    Patent number: 8586080
    Abstract: Compositions and methods for the continuous and controlled transdermal delivery of an active agent from a pharmaceutically acceptable carrier composition comprising a polyoxazoline polymer, wherein the active drug incorporated in the carrier composition of the transdermal system remains substantially solubilized and stable during storage prior to use.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: November 19, 2013
    Assignee: Noven Pharmaceuticals, Inc.
    Inventors: Rod Hartwig, David Kanios
  • Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
    Patent number: 8343538
    Abstract: A blend of at least two polymers in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin.
    Type: Grant
    Filed: October 7, 2005
    Date of Patent: January 1, 2013
    Assignee: Noven Pharmaceuticals, Inc.
    Inventors: David Kanios, Rod Hartwig
  • TRANSDERMAL DELIVERY OF KETOPROFEN POLAR DERIVATES
    Publication number: 20110263705
    Abstract: A topical or transdermal composition including a polar derivative of ketoprofen and a pharmaceutically acceptable topical or transdermal carrier, wherein the polar derivative of ketoprofen comprises a polarity that is greater than that of ketoprofen.
    Type: Application
    Filed: July 1, 2011
    Publication date: October 27, 2011
    Inventors: Rod Hartwig, David Houze
  • Transdermal delivery of ketoprofen polar derivatives
    Patent number: 7989496
    Abstract: A topical or transdermal composition including a polar derivative of ketoprofen and a pharmaceutically acceptable topical or transdermal carrier, wherein the polar derivative of ketoprofen comprises a polarity that is greater than that of ketoprofen.
    Type: Grant
    Filed: October 25, 2007
    Date of Patent: August 2, 2011
    Assignee: Noven Pharmaceuticals, Inc.
    Inventors: Rod Hartwig, David Houze
  • COMPOSITIONS AND METHODS FOR CONTROLLING DRUG LOSS AND DELIVERY IN TRANSDERMAL DRUG DELIVERY SYSTEMS
    Publication number: 20100310610
    Abstract: A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or release liner. The transdermal delivery device is manufactured to optimize drug loading while providing desirable adhesion to skin or mucosa as well as providing modulation of the drug delivery and profile.
    Type: Application
    Filed: June 3, 2010
    Publication date: December 9, 2010
    Inventors: David P. Kanios, Rod Hartwig, Juan A. Mantelle, David W. Houze
  • TRANSDERMAL DELIVERY OF KETOPROFEN POLAR DERIVATIVES
    Publication number: 20090062394
    Abstract: A topical or transdermal composition including a polar derivative of ketoprofen and a pharmaceutically acceptable topical or transdermal carrier, wherein the polar derivative of ketoprofen comprises a polarity that is greater than that of ketoprofen.
    Type: Application
    Filed: October 25, 2007
    Publication date: March 5, 2009
    Inventors: Rod HARTWIG, David HOUZE
  • Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
    Publication number: 20080063698
    Abstract: The invention relates to compositions and methods for making a transdermal drug delivery system capable of achieving substantially zero-order kinetics for delivery of the active agent over a period of time in excess of 24 hours and at least 72 hours, comprising a pharmaceutically acceptable active agent carrier and a rosin ester which provides a crystal inhibiting and drug stabilizing effect on the active agents incorporated therein.
    Type: Application
    Filed: August 29, 2007
    Publication date: March 13, 2008
    Inventor: Rod Hartwig
  • Compositions and methods for delivering estradiol in transdermal drug delivery systems
    Publication number: 20060078601
    Abstract: A blend of at least two polymers in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin.
    Type: Application
    Filed: October 7, 2005
    Publication date: April 13, 2006
    Inventors: David Kanios, Rod Hartwig
  • Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
    Publication number: 20050169977
    Abstract: A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or release liner. The transdermal delivery device is manufactured to optimize drug loading while providing desirable adhesion to skin or mucosa as well as providing modulation of the drug delivery and profile.
    Type: Application
    Filed: October 28, 2004
    Publication date: August 4, 2005
    Inventors: David Kanios, Rod Hartwig, Juan Mantelle, David Houze